Fundraising FoxAqua Medical
Santa Ana, US · Founded 2016 · Delaware corporation · 2 known investors
Find your way into Aqua Medical
Sign up to see every warm intro you have to Aqua Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aqua Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Through-the-endoscope vapor ablation platform for treating metabolic disease and type 2 diabetes via transoral duodenal ablation
Founders & leadership
SM
SEAN McWEENEYExecutive
HA
HAZIM ANSARIExecutive
LM
Lloyd MencingerExecutive
VS
VIRENDER SHARMANamed on SEC filing
Board
GB
GREG BARRETTBoard director
MG
MARK GILREATHBoard director
Investors · 2
Relevance Ventureslisted by Relevance VenturesBrentwood · $250K – $2.5M
How we know: Relevance Ventures's portfolio page · Not right? Tell us
ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto
How we know: ShangBay Capital LLC's portfolio page · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$10.1M disclosed across 3 of 4 rounds · 2017–2020
- Undisclosed amountseries AJul 2018Source ↗
▶$6.8MraisedJul 2020 · 16 investors · OtherRule 506(b)
▶$6.8MraisedJul 2020 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael BlomeyerDirector
- Lloyd MencingerExecutive Officer, Director
- Greg BarrettDirector
- Mark GilreathDirector
- William DaiDirector
- Virender K. SharmaDirector
- Offering amount
- $8.3M
- Amount sold
- $6.8M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.1MraisedFeb 2019 · 16 investors · OtherRule 506(b)
▶$3.1MraisedFeb 2019 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lloyd MencingerExecutive Officer, Director
- Greg BarrettDirector
- Mark GilreathDirector
- Virender K. SharmaDirector
- Offering amount
- $3.7M
- Amount sold
- $3.1M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$205KraisedMar 2017 · 2 investors · BiotechnologyRule 506(b)
▶$205KraisedMar 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL MADDENExecutive Officer
- GREG BARRETTDirector
- VIRENDER SHARMAExecutive Officer, Director
- SEAN McWEENEYExecutive Officer
- MARK GILREATHDirector
- HAZIM ANSARIExecutive Officer
- LLOYD MENCINGERExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $205K
- Minimum investment
- $25K
- Proceeds to insiders
- $600K
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aqua Medical do?
- Through-the-endoscope vapor ablation platform for treating metabolic disease and type 2 diabetes via transoral duodenal ablation
- Who are Aqua Medical's investors?
- Aqua Medical's investors include Relevance Ventures, ShangBay Capital LLC.
- How much funding has Aqua Medical raised?
- Aqua Medical has disclosed $10.1M raised across 3 of its 4 known rounds.
- Where is Aqua Medical headquartered?
- Aqua Medical is headquartered in Santa Ana, US.